Introduction
Enteroviruses are members of the genus Enterovirus in the family Picornaviridae, order Picornavirales. The type member of the genus is poliovirus, the etiologic agent of poliomyelitis and a member of Enterovirus species C (EV-C); one of the twelve species in the genus [1] . EV-B has most (>60) of the enterovirus serotypes that have been described till date [1] . Classically, serotypes were defined using neutralization assay [2, 3] . More recently, a correlation has been found between the nucleotide sequence of the VP1 gene and serotypes [2, 3] . Consequently, the nucleotide sequence of the VP1 gene is being used for enterovirus serotype/genotype designation, and has allowed the discovery of several new types [1] .
Majority of the nonpolio enteroviruses (NPEVs) isolated till date were isolated courtesy the poliovirus eradication effort (Global Polio Eradication Initiative [GPEI]). The GPEI was inaugurated in 1988 via a World Health Assembly (WHA) resolution to eradicate poliovirus [4] .
The effort has centered on intensive vaccination (with both oral and inactivated polio vaccines [OPV and IPV]), and surveillance (for poliovirus in children <15 years old with acute flaccid paralysis (AFP) and sewage contaminated water) [5] [6] [7] .
As part of the surveillance effort is a team of about 140 laboratories (Global Polio Laboratory Network [GPLN] ) that are WHO certified and responsible for poliovirus laboratory diagnosis globally in accordance with the WHO guidelines [5, 6] . These guidelines have isolation of poliovirus in cell lines (RD and L20B) as the core on which the rest of the algorithm is built.
Though very sensitive for poliovirus detection and identification, studies have shown that the RD-L20B algorithm also selectively supports EV-B detection while not significantly supporting nonpolio EV-C (NPEV-C) isolation [8] [9] [10] . This suggests that some NPEVs are missed by the RD-L20B algorithm. Furthermore, we have previously shown [9] that by including a cell line like MCF 7 in the isolation algorithm, enteroviruses that had been missed by the RD-L20B algorithm can be subsequently recovered from sewage contaminated water (environmental) samples.
Recently [11] , a reverse transcriptase semi-nested polymerase chain reaction (RT-snPCR) assay (first described by Nix et al., [12] ) was recommended by the WHO for direct detection of enteroviruses from clinical specimen. The sensitivity of this assay has been confirmed by several studies [13] [14] [15] [16] and we have further improved the assay by enhancing its enterovirus co-infection resolution capacity [16] .
In this study, we use the WHO recommended RT-snPCR assay [11] and its modification [16] to screen AFP samples that had been previously screened, and declared negative for enteroviruses using the RD-L20B algorithm [6] . We show that about 50% of the samples had enteroviruses in them and EV-Cs were the predominant species recovered.
Methodology

Sample Collection and Processing
The samples analyzed in this study were obtained from the WHO National polio laboratory at the Department of Virology, College of Medicine, University of Ibadan, Nigeria. These stool suspensions were collected in 2015 as part of the national Acute Flaccid Paralysis (AFP) surveillance program in different states of Nigeria. The samples were previously analyzed in the polio laboratory in accordance with the WHO cell culture based algorithm recommended for poliovirus isolation [6] in order to determine the presence or otherwise of polioviruses and NPEVs in them.
Thirty cases whose samples showed no cytopathology in RD and L20B cell lines [6] and were consequently declared negative for enteroviruses were selected at random and analyzed in this study. The 30 cases consisted of 60 samples (two samples for each case collected within 24 hours). Each of the 30 paired samples was pooled (i.e. making 30 samples) and analyzed. In addition, two samples that had been earlier confirmed to contain enteroviruses were included to serve as positive controls. µL of each of the oligonucleotide primers AN32, AN33, AN34, and AN35 [11, 12] . Then, 5.25µL of RNA extract was added to make 10µL. This mixture was incubated at 42°C for 10 minutes followed by 50°C for 60 minutes in a Veriti thermocycler (Applied Biosystems, California, USA).
RNA Extraction and cDNA Synthesis
Semi-nested Polymerase chain reaction (snPCR) Screens
One first round and three (PE, EV-A/C, EV-B) different second round PCR assays were done.
For the first round PCR assay, the reactions were done in 30µL volumes. Each contained 6µL of Red Load Taq, 13.4µL of RNase free water and 0.3µL each of the forward (224) and reverse (222) primers, and 10µL of cDNA. A Veriti thermal cycler (Applied Biosystems, California, USA) was used for thermal cycling with the following conditions; 94 0 C for 3 minutes, followed by 45 cycles of 94 0 C for 30 seconds, 42 0 C for 30 seconds, and 60 0 C for 60 seconds, with ramp of 40% from 42 0 C to 60 0 C. This was then followed by 72 0 C for 7 minutes, and held at 4 0 C until the reaction was terminated.
All three second-round PCR assays were carried out with the first-round PCR product as template, with similar thermal cycling conditions except for the extension time that was reduced to 30 seconds. The same reverse primer (AN88) was used for all three second round PCR assays.
The forward primers were AN89, 189 and 187 for Panenterovirus (PE), Enterovirus Species A or C (EV-A/C) and Enterovirus Species B (EV-B) PCR assays, respectively. Subsequently, all PCR products were resolved on 2% agarose gels stained with ethidium bromide and viewed using a UV transilluminator.
Amplicon Sequencing and Enterovirus Identification.
Amplicons of all the second round PCR assays with the expected band size (i.e. ~350 bp) were shipped to Macrogen Inc, Seoul, South Korea, for purification and nucleotide sequencing.
Afterwards, the enterovirus genotyping tool (EGT) [17] was used for enterovirus species and genotype determination.
Multiple Sequence Alignment (MSA)
Subsequent to enterovirus identification via the EGT [17] , for nucleotide sequences generated from selected amplicons, multiple sequence alignments were done using reference sequences downloaded from Genbank and aligned using the CLUSTAL W program in MEGA 5 software with default settings [18] .
Nucleotide Sequence Accession Numbers. All the sequences generated in this study have been deposited in GenBank under accession numbers KY748282-KY748295.
RESULTS
PCR Result
The PE assay successfully amplified the expected ~350bp from 15 of the 30 (50%) samples screened in this study and the two controls. The EV-A/C assay successfully amplified the expected ~350bp from 11 of the 30 (36.7%) samples screened as well as the two controls. The EV-B assay successfully amplified the expected ~350bp from nine (9) of the 30 (30%) samples screened as well as the two controls. Altogether, amplicons were recovered from 15 of the 30 (50%) samples screened as well as the two controls (Table 1) .
Sequencing and Genotyping Result
For the PE assay, of the 15 amplicons generated, 13 were successfully sequenced alongside the two controls, while two (2) were not due to very weak bands. The isolates were identified as Enterovirus (EV) A119 (1 isolate), Echovirus-21 (E21) (1 isolate), EV-B97 (1 isolate), EV-B111
(1 isolate), Poliovirus 2 (PV-2) (1 isolate), CV-A13 (2 isolates), CV-A17 (1 isolate), CV-A20 (1 isolate) and EV-C99 (4 isolates), Specifically, of the 13 isolates detected by the PE assay, one, three and nine belong to EV-A, EV-B and EV-C respectively. The two controls were identified as EV-C99 and CV-A1, both EV-Cs (Table 1) .
For the EV-A/C assay, all the 11 amplicons were successfully sequenced alongside the two controls, and identified as EV-A119 (1 isolate), PV-2 (1 isolate), CV-A13 (2 isolates), CV-A17
(1 isolate), CV-A20 (2 isolate), and EV-C99 (4 isolates). Of the eleven isolates detected by this study, ten belong to EV-C while one was EV-A. The two controls were identified as EV-C99 and CV-A1, both EV-Cs (Table 1) .
For the EV-B assay, all the nine (9) amplicons and the two controls were successfully sequenced.
However, sequence data from five of the isolates and the two controls were unexploitable due to the presence of multiple peaks. The remaining four isolates were successfully typed and identified as Echovirus 21 (E21) (1 isolate), E25 (1 isolate), EV-B97 (1 isolates) and EV-B111
(1 isolate). All the four identified isolates were EV-Bs.
Co-infection resolution
Overall, these assays showed that only sample number one contained a mixture (EV-C99 and E25) and this was resolved ( Table 1) . It is however important to note that, had we relied on only the PE assay as recommended by the WHO, the presence of E25 in the sample would have been missed. Similarly, we might have missed CV-A20 in sample 23 (Table 1) had we relied on PE assay alone.
Sequence based determination of the type of Poliovirus serotype 2 detected
Multiple sequence alignment ( Figure 1 ) showed that the Poliovirus serotype 2 (PV-2) detected had the amino acid Isoleucine at the 143 rd position of the VP1 protein suggesting it to be a vaccine strain. (Table 1 ). This study therefore confirms the circulation and preponderance of EV-Cs in Nigeria. Other studies where cell lines with EV-C 'bias' (e.g. HEp-2c or MCF-7) were incorporated into the cell culture algorithm also reported preponderance of EV-Cs [8, 9] . It is however important to mention that previous studies in the region that, like the GPLN, used the RD-L20B cell culture based algorithm [19] [20] [21] reported a preponderance of EV-Bs. The obvious dissimilarity between the results of these studies might therefore be the cell culture algorithm.
Evidently, the RD-L20B algorithm had selectively filtered out majority of the EV-B containing samples (bearing in mind the EV-B bias of RD cell line [8, 9, 20] ), leaving behind more of EV-C containing samples. Hence, it is not unexpected to recover more EV-Cs than EV-Bs in this study.
The results of this study therefore add more credence to the EV-B bias hypothesis of RD cell line.
The modifications [16] to the WHO recommended RT-snPCR assays showed that 3.3% (1/30) of the culture negative stool samples from AFP cases analyzed in this study using the WHO recommended RT-snPCR assay had evidence of being mixed (i.e. the case had co-infection with two different enterovirus types). The sample (serial number 1) was shown to contain both EV-B
and C (EV-C99 and E25) ( Table 1 ). The inability of the WHO recommended RT-snPCR VP1 assay [11] to detect and resolve mixed isolates has been previously discussed [16] . Hence, as previously suggested [16] , the modification of the WHO recommended assay [11] to include independent use of primers 187 and 189 (forward primers) alongside AN88 (reverse primer) for the second round PCR, ensured that the assay retained its sensitivity for enterovirus detection, while providing a simple method to identify and resolve co-infection with different enterovirus types. It is therefore crucial that we do not allow our desire for a panenterovirus detection assay to overshadow our ability to adequately catalogue all enterovirus types present in cases of coinfection.
One of the important isolates detected in this study is a poliovirus serotype 2 (PV-2). It was further shown (Figure 1 ) that the amino acid at the 143 rd position of the VP1 protein was an Isoleucine (Ile 143 ), implying that the virus was a vaccine (Sabin) strain [22] . Why this virus was missed by the WHO recommended RD-L20B cell culture based algorithm [5, 6] is currently not clear. Possibilities include break in reverse cold-chain enroute the laboratory and the consequent arrival of the samples with nonviable virus. It is also possible that this PV-2 might represent one of those described by Arita et al., [23] that cannot use the poliovirus receptor (PVR), which is a prerequisite for replication in RD and L20B cell lines. Hence, the inability of the cell lines to detect it. Whatever be the case, the finding of PV-2 in a sample declared negative for such highlights the value of the WHO recommended RT-snPCR assay for detection of enteroviruses even in cases where the enterovirus present might not be detectable by the WHO recommended RD-L20B cell culture based algorithm [5, 6] . This therefore demonstrates the need to use the assay to screen samples declared negative by the RD-L20B cell culture based algorithm before samples are completely ruled as truly negative for poliovirus. The significance of this to the poliovirus eradication effort cannot be over emphasized.
Among all the enterovirus types detected in this study, EV-A119 and EV-B111 are being described for the first time in Nigeria. The significance of this first find of EV-A119 in a child with a clinical condition, particularly AFP, and its zoonotic potential has been described [24].
As regards EV-B111, as at the 4 th of March 2017, only three publicly available sequence data of EV-B111 (KF312882, JX538160 and JX538130) existed in GenBank and they were all from South-East Asia. This might therefore represent its first description in Africa. routinely for cell culture in most enterovirology laboratories. Consequently, it is and will mostly be detected by cell culture independent methods like the WHO recommended RT-snPCR assay [11] used in this and the other study [26] that detected it. On the other hand, as evidenced by its varying serology ten years after its description in different prefectures of the same region in China, it is also likely that EV-B111 is not well established in the human population and thus not circulating efficiently [25] . However, as tempting as this proposition is, the fact that EV-B111
has been found at least four times and on two different continents over the last 16 years is course for concern. Furthermore, if EV-B111 is not well adapted to humans, then where has it been surviving and circulating between detections. More troubling is the fact that besides its finding in 
